Atossa Genetics Inc. closed its underwritten public offering with gross proceeds of about $4.4 million.
The offering included 664,000 class A units at 75 cents apiece, which consisted of 664,000 common shares and warrants to purchase 664,000 common shares.
In addition, the offering included 3,502 class B units at $1,000 apiece, which consisted of 3,502 series A convertible preferred shares convertible into a total of 4,669,333 common shares and warrants to purchase 4,669,333 common shares.
The underwriter exercised the overallotment option to buy an additional 530,000 common shares and warrants to purchase 530,000 common shares, which are included in the estimated gross proceeds of $4.4 million. The warrants can be exercised at 93.75 cents per share and will expire five years from the date of issuance.
Aegis Capital Corp. acted as the sole book-running manager for the offering.